Innovator IBD 50 ETF (NYSEARCA:FFTY) Short Interest Update

Innovator IBD 50 ETF (NYSEARCA:FFTY) saw a significant increase in short interest during the month of June. As of June 15th, there was short interest totaling 51,245 shares, an increase of 81.6% from the May 31st total of 28,220 shares. Currently, 2.2% of the company’s shares are sold short. Based on an average daily volume of 46,880 shares, the short-interest ratio is presently 1.1 days.

Hedge Funds Weigh In On Innovator IBD 50 ETF

Hedge funds and other institutional investors have recently bought and sold shares of the company. AlphaCore Capital LLC acquired a new position in shares of Innovator IBD 50 ETF in the 4th quarter valued at about $32,000. International Assets Investment Management LLC bought a new stake in Innovator IBD 50 ETF in the 4th quarter valued at about $35,000. Simplex Trading LLC acquired a new position in Innovator IBD 50 ETF during the 4th quarter worth approximately $41,000. Advisory Services Network LLC acquired a new position in Innovator IBD 50 ETF during the 3rd quarter worth approximately $43,000. Finally, Kestra Advisory Services LLC bought a new position in Innovator IBD 50 ETF in the fourth quarter worth approximately $72,000.

Innovator IBD 50 ETF Stock Performance

Shares of NYSEARCA FFTY opened at $40.66 on Friday. The stock has a market cap of $87.42 million, a P/E ratio of 30.34 and a beta of 1.45. Innovator IBD 50 ETF has a 52-week low of $31.42 and a 52-week high of $44.08. The firm has a 50 day moving average price of $40.72 and a two-hundred day moving average price of $38.05.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.